Table 3 Clinical outcomes of non-diabetic patients with STEMI based on MAGE and ABG
| Â | MAGE (mmol/L) | ABG (mmol/L) | ||||
|---|---|---|---|---|---|---|
≤3.26 | >3.26 | p | ≤7.80 | >7.80 | p | |
n | 170 | 86 | Â | 170 | 86 | Â |
Peak CK (U/L) | 905 (300–4077) | 1290 (471–4658) | 0.020 | 897 (300–4428) | 1372 (398–4658) | 0.039 |
GRACE score | 140 ± 33 | 152 ± 34 | 0.005 | 141 ± 34 | 150 ± 33 | 0.036 |
MACE | 20 (13.5) | 30 (31.4) | 0.001 | 26 (15.9) | 24 (26.7) | 0.046 |
 Cardiac death | 1 (0.6) | 5 (5.8) | 0.017 | 2 (1.2) | 4 (4.7) | 0.100 |
 New-onset MI | 3 (1.8) | 5 (5.8) | 0.123 | 4 (2.4) | 4 (4.7) | 0.448 |
 Acute HF | 4 (2.4) | 11 (12.8) | 0.001 | 7 (4.1) | 8 (9.3) | 0.156 |
 TVR | 12 (7.1) | 9 (10.5) | 0.346 | 13 (7.6) | 8 (9.3) | 0.637 |